| Literature DB >> 33013034 |
Reem Abdelraouf ElSharkawy1, Tamer Elmetwally Farahat1, Khaled Abdelwahab2.
Abstract
BACKGROUND AND AIMS: This study was conducted to compare continuous preperitoneal infusion (CPI) with continuous epidural infusion (CEI) of ropivacaine for pain relief and effect on pulmonary functions after major abdominal and pelvic surgeries.Entities:
Keywords: Abdominal tumors; epidural infusion; pelvic tumors and ropivacaine; preperitoneal infusion
Year: 2020 PMID: 33013034 PMCID: PMC7480288 DOI: 10.4103/joacp.JOACP_333_18
Source DB: PubMed Journal: J Anaesthesiol Clin Pharmacol ISSN: 0970-9185
Demographic and surgical characteristics. Data were presented in mean±SD or number and percentage of the patients
| Group CPI ( | Group CEI ( | ||
|---|---|---|---|
| Demographics | |||
| Age (years) | 46.8±7.0 | 45.6±6.9 | 0.4 |
| Gender (M/F) | 14/33 | 11/37 | 0.4 |
| BMI (kg/m2) | 29.6±3.8 | 30.2+3.5 | 0.7 |
| ASA I | 31 (65.1%) | 32 (66.7%) | 0.9 |
| ASA II | 16 (34.0%) | 16 (33.3%) | 0.9 |
| Operative time (min) | 162±28.2 | 156.52+33.4 | 0.3 |
| Length of the wound (cm) | 15.8±4.6 | 16.2±4.8 | 0.7 |
| Type of tumor | |||
| Uterine carcinoma | 13 (27.7%) | 15 (31.3%) | |
| Cancer colon | 13 (27.7%) | 11 (22.9%) | 0.9 |
| Ovarian cancer | 10 (21.3%) | 15 (31.3%) | |
| Urinary tumor | 11 (23.4%) | 7 (14.6%) | |
| Tumor pathology | |||
| Malignant | 35 | 37 | 0.7 |
| Nonmalignant | 12 | 11 | |
| First request of analgesia (h) | 7.3±1.6 | 4.07±1.1* | 0.001 |
| The dose of morphine on the first postoperative day | 11.3±1 | 17.39±0.9* | 0.001 |
| The dose of morphine on the second postoperative day | 7.06±0.9 | 13.25±0.9* | 0.001 |
SD: Standard deviation; CPI: Continuous preperitoneal infusion; CEI: Continuous epidural infusion; BMI: Body mass index; ASA: American Society of Anesthesiologists. *P-value≤0.05: Statistically significant
The postoperative assessment of pain within the studied groups measured by the visual analogue score (VAS). Data presented as median (IQR)
| Group CPI ( | Group CEI ( | P | |||
|---|---|---|---|---|---|
| Median | IQR | Median | IQR | ||
| 1 h | 3 | (2-4) | 3 | (2-4) | 0.6 |
| 2 h | 3 | (2-4) | 3 | (2-4) | 0.7 |
| 4 h | 2 | (0-4) | 3 | (3-4)* | 0.001 |
| 8 h | 3 | (2-4) | 4 | (3-5)* | 0.001 |
| 12 h | 3 | (1-3) | 4 | (3-5)* | 0.001 |
| 16 h | 2 | (1-3) | 3 | (2-4)* | 0.001 |
| 24 h at rest | 3 | (2-4) | 4 | (2-5)* | 0.001 |
| 24 h at cough | 3 | (4-5) | 4 | (4-5)* | 0.001 |
| 48 h at rest | 1 | (0-3) | 2 | (2-3)* | 0.001 |
| 48 h at cough | 2 | (2-4) | 3 | (3-4)* | 0.01 |
CPI: Continuous preperitoneal infusion; CEI: Continuous epidural infusion; CI: Confidence interval. *P-value ≤ 0.05: Statistically significant
Figure 1The recorded changes in the respiratory rate in the studied groups
Figure 2(a) The recorded changes of postoperative mean arterial blood pressure (mmHg) in the studied groups. (b) The recorded changes of postoperative heart rate (beat/min) in the studied groups
Preoperative and postoperative pulmonary function tests (FVC, FVE1), the ratio between them, PEFR, and CRP during the first 48 h. Data were expressed in mean±SD
| Group CPI ( | Group CEI ( | ||||
|---|---|---|---|---|---|
| Mean | SD | Mean | SD | ||
| FVC (%) | 86.1±2.9 | 87.0±2.8 | 0.8 | ||
| 48 h | 87.8±2.8 | 87.4±2.9 | 0.5 | ||
| FEV1 (%) | |||||
| Basal | 97.8±1.3 | 97.9±1.6 | 0.7 | ||
| 24 h | 97.1±3.6 | 97.6±3.5 | 0.5 | ||
| 48 h | 97.5±3.5 | 97.6±3.3 | 0.9 | ||
| PEFR | |||||
| Basal | 282.0±6.4 | 274.9±6.0* | 0.001 | ||
| 24 h | 170.5±5.4 | 148.1±5.8* | 0.001 | ||
| 48 h | 191.8±6.7 | 164.5±5.4* | 0.001 | ||
| FEV1/FVC | 1.1±0.1 | 1.1±0.1 | 0.9 | ||
| Basal | 1.1±0.1 | 1.1±0.1 | 0.8 | ||
| 24 h | 1.1±0.1 | 1.1±0.1 | 0.6 | ||
| 48 h | |||||
| CRP | 35.3±3.8 | 39.9±5.9* | 0.001 | ||
FVC1: Forced vital capacity, FEV1: Forced expired volume, PEFR: Peak expiratory flow rate, CRP: C-reactive protein; CPI: Continuous preperitoneal infusion; CEI: Continuous epidural infusion. *P-value≤0.05: Statistically significant